Inventor · disambiguated record
Wu Du
Also filed as: CURRAN DENNIS P · DU WU
16 granted patents·16 pending applications·21 citations·filing 2001–2024
87Inventor score
Files withHINOVA PHARMACEUTICALS INC20PTC THERAPEUTICS INC6UNIV PITTSBURGH2BRANSTROM ARTHUR1DOBBELAAR PETER H1
Top patents by PatentIndex Score
32 records- 0181US10370371B2Substituted pyrimidine Bmi-1 inhibitorsPTC THERAPEUTICS INC·Filed 2013·Granted Aug 6, 2019·3 cites·7 claims
- 0280US10428050B2Substituted reverse pyrimidine Bmi-1 inhibitorsPTC THERAPEUTICS INC·Filed 2013·Granted Oct 1, 2019·4 cites·8 claims
- 0378US11180483B2Substituted reverse pyrimidine Bmi-1 inhibitorsPTC THERAPEUTICS INC·Filed 2019·Granted Nov 23, 2021·1 cites·16 claims
- 0476US6372906B1Synthesis of silyl camptothecins and silyl homocamptothecinsUNIV PITTSBURGH·Filed 2001·Granted Apr 16, 2002·8 cites·39 claims
- 0572US2025082763A1Combination drug for treating triple-negative breast cancerHINOVA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0672US2025082764A1Drug for treating triple negative breast cancerHINOVA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0771US10584115B2Substituted pyridine and pyrazine BMI-1 inhibitorsPTC THERAPEUTICS INC·Filed 2013·Granted Mar 10, 2020·1 cites·17 claims
- 0870US2022064150A1Substituted reverse pyrimidine bmi-1 inhibitorsPTC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0969US7064202B1Camptothecin intermediates and prodrugs and methods of preparation thereofUNIV PITTSBURGH·Filed 2004·Granted Jun 20, 2006·4 cites·2 claims
- 1060US11926618B2Halogen-substituted phenylate compound and applications thereofHINOVA PHARMACEUTICALS INC·Filed 2020·Granted Mar 12, 2024·0 cites·11 claims
- 1157US12194040B2FAK inhibitor and drug combination thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Jan 14, 2025·0 cites·5 claims
- 1256US11891379B2Deuterated Defactinib compound and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Feb 6, 2024·0 cites·12 claims
- 1353US2025250254A1Deuterated heterocyclic ketone compound and use thereofHINOVA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1453US2024277710A1Pharmaceutical composition for treatment of cancer and use thereofHINOVA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1552US2025051347A1Bifunctional chimeric heterocyclic compound and use thereof as androgen receptor degraderHINOVA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1651US2021290553A1Hc-1119 formulation, preparation method and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1748US2024059678A1Synthesis Method for Aminopyrimidine FAK Inhibitor CompoundHINOVA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1845US9975878B2Substituted triazine BMI-1 inhibitorsPTC THERAPEUTICS INC·Filed 2013·Granted May 22, 2018·0 cites·19 claims
- 1944US11447477B2Indoleamine-2,3-dioxygenase inhibitor, the preparative method and the use thereofHINOVA PHARMACEUTICALS INC·Filed 2018·Granted Sep 20, 2022·0 cites·1 claims
- 2044US2021292304A1Deuterated mgl-3196 compound and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2143US2022177459A1Aromatic amine compound and use thereof in preparation of ar and brd4 dual inhibitors and regulatorsHINOVA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2242US11591301B2Indoleamine-2,3-dioxygenase inhibitor, preparation method therefor and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Feb 28, 2023·0 cites·14 claims
- 2342US2023091225A1Bifunctional chimeric heterocyclic compounds for targeted degradation of androgen receptors and use thereofHINOVA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2442US2022087996A1Histone acetylase p300 inhibitor and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2542US2022257774A1Aromatic amine ar ahd bet targeting protein degradation chimera compound and useHINOVA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2641US11753392B2Method for synthesis of deuterated amide and deuterated sulfonamideHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Sep 12, 2023·0 cites·26 claims
- 2741US9650395B2Antibacterial compounds and methods for useBRANSTROM ARTHUR·Filed 2012·Granted May 16, 2017·0 cites·19 claims
- 2841US2010184758A1Beta carboline derivatives as antidiabetic compoundsDOBBELAAR PETER H·Filed 2008·Application pending·0 cites
- 2938US7064206B1Highly lipophilic camptothecin intermediates and prodrugs and methods of preparation thereofUNIV PITTSBURG·Filed 2004·Granted Jun 20, 2006·0 cites·2 claims
- 3036US10450274B2Quinoline compounds, preparation methods thereof, and uses thereof as urate transporter inhibitor drugHINOVA PHARMACEUTICALS INC·Filed 2016·Granted Oct 22, 2019·0 cites·13 claims
- 3134US2010184799A1Oxadiazole beta carboline derivatives as antidiabetic compoundsDU WU·Filed 2010·Application pending·0 cites
- 3230US2020087261A1Method for preparing deuterated imidazole diketone compoundHINOVA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wu Du files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →